Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Anti-Rabies Serum Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The anti-rabies serum market size has witnessed robust expansion in recent years. Its value is projected to increase from $1.5 billion in 2025 to $1.58 billion in 2026, maintaining a compound annual growth rate (CAGR) of 5.6%. Historically, this growth can be attributed to factors such as an escalating incidence of rabies exposure cases, the expansion of hospital-based emergency treatment protocols, the accessibility of equine-derived immunoglobulins, governmental support for rabies control initiatives, and a rising public awareness of post-exposure prophylaxis.
The anti-rabies serum market size is anticipated to experience substantial growth in the upcoming years. It is projected to reach $1.95 billion in 2030, showing a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period can be attributed to factors such as the increasing adoption of human anti-rabies immunoglobulin, the broadening of rabies prevention initiatives in developing regions, rising investments in biologics manufacturing, a growing emphasis on safer serum alternatives, and the strengthening of public health vaccination frameworks. Major trends expected in this period include the increasing use of human-derived immunoglobulins, a rising preference for prefilled syringe formats, the expansion of cold-chain optimized serum distribution, a heightened focus on high-purity antibody formulations, and improved standardization of post-exposure prophylaxis protocols.
Get A Free Sample Report With In-Depth Market Insights:
Anti-Rabies Serum Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing incidence of dog bites is anticipated to stimulate the expansion of the anti-rabies serum market. Dog bites are defined as injuries sustained when a dog bites or scratches a person, ranging in severity from minor to severe. These injuries can lead to infections, serious wounds, and, in some cases, the transmission of diseases like rabies. Effective prevention and immediate medical attention are essential for managing and minimizing the risks associated with dog bites. The escalating prevalence of dog bites is attributable to several factors, including heightened urbanization, which leads to more frequent interactions between people and dogs, a greater number of unrestrained or inadequately trained dogs, and insufficient public awareness or education regarding dog behavior and bite prevention. This rise in dog bite prevalence has subsequently increased the demand for anti-rabies serum, as its timely administration is critical for preventing rabies onset in individuals exposed to potentially infected animals. For instance, in 2023, the American Veterinary Medical Association, a US-based non-profit organization, stated that the average cost for dog bite insurance claims was $58,545. Insurers paid out $1.12B in liability claims related to dog bites and other dog-related injuries in 2023, with these claims increasing by nearly 10% in 2023. Thus, the growing prevalence of dog bites is a key driver for the growth of the anti-rabies serum market.
Anti-Rabies Serum Market Segments: Where Is Growth Concentrated?
The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals
Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Anti-Rabies Serum Market Innovation Trends Shaping Future Development
Leading firms within the anti-rabies serum market are engaging in strategic collaborations with the goal of improving product innovation and broadening their market presence. These alliances represent a method where businesses utilize one another’s capabilities and assets to attain shared advantages and successful outcomes. An example of this is the July 2023 collaboration between Kedrion S.p.A., a US-based biopharmaceutical company, and Kamada, an Israel-based biopharmaceutical company, for the distribution of KEDRAB (Rabies Immune Globulin [Human]) within the US. This partnership has been crucial for the joint development and licensing of the product in the U.S., concurrently fostering greater awareness about the disease. As a result of their combined initiatives, the alliance has contributed to safeguarding people exposed to bites from rabid animals against severe and potentially fatal illnesses.
Anti-Rabies Serum Market Key Participants And Competitive Landscape
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
View The Full Anti-Rabies Serum Market Report:
Anti-Rabies Serum Market Geographic Spread And Regional Opportunities
North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
